Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
Clinical trial NCT06350162 · UNKNOWN
Trial details
- NCT number
- NCT06350162
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2024-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.